Investor directoryLeaps by Bayer
Leaps by Bayer aims to solve ten of the world's biggest challenges through scientific breakthroughs in health and agriculture.
What they invest in
Geographies
North AmericaEurope
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- Leverkusen, Germany
- Founded
- 2015
Portfolio companies
More portfolio companies
Arvinas (NAS: ARVN)TranscarentMetagenomi Therapeutics (NAS: MGX)BlueRock TherapeuticsCelea TherapeuticsRecursion Pharmaceuticals (NAS: RXRX)AgBiomeCentury Therapeutics (NAS: IPSC)Paratus SciencesTriumviraPairwiseReCode TherapeuticsCurie.BioDewpoint TherapeuticsCapstan TherapeuticsAffini-TAda HealthNumerion LabsSound AgricultureEgenesisSoufflé TherapeuticsOne DropNextPointBoundless Bio (NAS: BOLD)
and 25 more
Questions founders ask
- How much does Leaps by Bayer typically invest?
- Leaps by Bayer states a typical cheque of €1M – €30M.
- Which stages does Leaps by Bayer invest in?
- Leaps by Bayer invests at Seed and Series A.
- Where is Leaps by Bayer based?
- Leaps by Bayer is headquartered in Leverkusen, Germany.
Does Leaps by Bayer fit your round?
In 30 minutes you'll know which funds matter for your round.
Get a demoSearch investors like this in Claude — no account, no sign-in. Open in Claude
Are you Leaps by Bayer? Tell us what to correct and we will update it — or ask us to remove the entry.